Showing results (111-120 of 125) with videos related to
Sort By:
Pageof 13
International Journal of Clinical Oncology|June 21, 2024
Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical OncologyTakeshi Hirose, Mamoru Ito, Kenji Tsuchihashi, et al.International Journal of Clinical Oncology|June 12, 2024
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical OncologyTakeshi Hirose, Mamoru Ito, Kenji Tsuchihashi, et al.International Journal of Clinical Oncology|March 18, 2024
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncologyTomoya Maeda, Yuho Najima, Yutaro Kamiyama, et al.International Journal of Clinical Oncology|June 20, 2024
Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022Kazuki Nozawa, Yukinori Ozaki, Tetsuhiro Yoshinami, et al.International Journal of Clinical Oncology|May 16, 2024
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical OncologyYuho Najima, Tomoya Maeda, Yutaro Kamiyama, et al.Scientific Reports|January 29, 2020
Identification of a novel uterine leiomyoma GWAS locus in a Japanese populationKensuke Sakai, Chizu Tanikawa, Akira Hirasawa, et al.International Journal of Clinical Oncology|April 22, 2024
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022Tetsuhiro Yoshinami, Kazuki Nozawa, Takamichi Yokoe, et al.International Journal of Clinical Oncology|February 11, 2025
Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022Takamichi Yokoe, Tetsuhiro Yoshinami, Kazuki Nozawa, et al.International Journal of Clinical Oncology|March 25, 2024
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022Yukinori Ozaki, Takamichi Yokoe, Tetsuhiro Yoshinami, et al.International Journal of Clinical Oncology|May 2, 2024
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical OncologyKenji Tsuchihashi, Mamoru Ito, Yuta Okumura, et al.Pageof 13